Imperial College London


Faculty of MedicineDepartment of Brain Sciences

Professor of Practice (Neurology)







12L12CLab BlockCharing Cross Campus





I work as part of the MS research team carrying out commercial and academic studies.  I am also involved in the biology of MS and novel imaging techniques.    



Simpson-Yap S, Pirmani A, Kalincik T, et al., 2022, Updated Results of the COVID-19 in MS Global Data Sharing Initiative: Anti-CD20 and Other Risk Factors Associated With COVID-19 Severity., Neurol Neuroimmunol Neuroinflamm, Vol:9

Simpson-Yap S, Pirmani A, De Brouwer E, et al., 2022, Severity of COVID19 infection among patients with multiple sclerosis treated with interferon-beta, Multiple Sclerosis and Related Disorders, Vol:66, ISSN:2211-0348

Owen D, 2022, Human pharmacokinetics of XBD173 and etifoxine distinguish their potential for pharmacodynamic effects mediated by TSPO, British Journal of Clinical Pharmacology, Vol:88, ISSN:0306-5251, Pages:4230-4236

Young CA, Mills RJ, Langdon D, et al., 2022, Measuring coping in multiple sclerosis: The Coping Index-MS, Multiple Sclerosis Journal, ISSN:1352-4585

Magliozzi R, Fadda G, Brown RA, et al., 2022, "Ependymal-in" Gradient of Thalamic Damage in Progressive Multiple Sclerosis, Annals of Neurology, ISSN:0364-5134

More Publications